Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Cell Death & Disease|May 23, 2019
TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathwayXiaoyan Fu, Huayong Zhang, Zhipeng Chen, et al.
International Journal of Surgery (London, England)|December 16, 2025
Navigating the lymphatic labyrinth: insights into lateral cervical metastasis patterns in papillary thyroid carcinoma a multicenter studyTaonong Cai, Zan Jiao, Yu Guo, et al.
Environmental Pollution (Barking, Essex : 1987)|January 4, 2025
Per- and polyfluoroalkyl substances (PFAS) exposure is associated with radioiodine therapy resistance and dedifferentiation of differentiated thyroid cancerYongchao Yu, Kang Ning, Xinyu Liu, et al.
Scientific Reports|July 23, 2024
Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinomaYu Miao, Qiaorong Chen, Xinyu Liu, et al.
The Annals of Otology, Rhinology, and Laryngology|August 30, 2022
Short-Term Efficacy of the Transnasal-Transoral Approach to Endoscopic Nasopharyngectomy for Nasopharyngeal AdenocarcinomaQingjian Tan, Qing Yang, Hao Li, et al.
Frontiers in Immunology|October 25, 2021
TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell CarcinomaQian Long, Chunyu Huang, Qi Meng, et al.
Head & Neck|April 9, 2014
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trialYe Guo, Mei Shi, Ankui Yang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 21, 2023
Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinomaShida Yan, Lili Liu, Xing Zhang, et al.
International Journal of Surgery (London, England)|August 27, 2025
Efficacy and safety of immunotherapy in anaplastic thyroid carcinoma: a systematic review and meta-analysisKang Ning, Qiaorong Chen, Yu Guo, et al.
Endocrine-Related Cancer|January 23, 2024
Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patientsXiangqian Zheng, Meiyu Fang, Yun Fan, et al.
Pageof 7